Elagolix
Elagolix (ABT-620) is an oral gonadotropin-releasing hormone antagonist being studied for the treatment of endometriosis, uterine fibroids and PCOS. |
Type of Molecule
Small MoleculeTarget
GnRHProduct Type
New IndicationPotential Indication | Region | Phase (1, 2, 3, Submitted) |
---|---|---|
Endometriosis | US |
Approved
|
Uterine Fibroids | n/a |
Approved
|
PCOS | n/a |
Phase 2
|